Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Estimated Useful Lives used to Depreciate Real Property Assets

Depreciation of our real property assets is charged to expense on a straight-line basis over the estimated useful lives
as follows:

Description	Standard Depreciable Life
Land	Not Depreciated
Buildings	35 years
Site Improvements	7-10 years

Summary of Portion of Sponsor Funding Received

Below is a summary of the portion of sponsor funding received which exceeds the fair value of the Series C Units issued:

Balance at December 31, 2024	$	3,777,104
Total consideration received		218,399
Reduction of Property operating expense - affiliates		(240,417	)
Balance at March 31, 2025	$	3,755,086

Summary of Fixed Rate Notes Payable

The table below summarizes our fixed rate notes payable at March 31, 2025, we had no fixed rate notes payable outstanding at December 31, 2024. The estimated fair value of financial instruments is subjective in nature and are dependent on a number of important assumptions, including discount rates and relevant comparable market information associated with each financial instrument. The fair value of our fixed and variable rate notes payable were estimated by discounting the future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. These assumptions are considered level 2 inputs within the fair value hierarchy. The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. As of March 31, 2025 and December 31, 2024, we believe the fair value of our variable rate debt are reasonably estimated at their notional amounts as there have been minimal changes to the fixed spread portion of interest rates for similar loans observed in the market, and as the variable portion of our interest rates fluctuate with the associated market indices.

	March 31, 2025				December 31, 2024
	Fair Value		Carrying Value		Fair Value		Carrying Value
Fixed Rate Secured Debt	$	124,520,200	$	124,520,200	$	-	$	-

Schedule of Assets and Liabilities Measured at Fair Value On Recurring Basis

The table below presents the Company's assets and liabilities measured at fair value on a recurring basis as of March 31, 2025, aggregated by the level in the fair value hierarchy within which those measurements fall:

	Fair Value Measurements at Reporting Date Using
Description	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other assets - interest rate hedges	$	—	$	1,582,548	$	—
Accounts payable and accrued liabilities - interest rate hedges	$	—	$	826,008	$	—
Other assets - foreign currency hedge	$	—	$	3,938,663	$	—

Schedule of Deferred Tax Asset

	March 31, 2025			December 31, 2024
Deferred tax asset:
Canadian real estate and non-capital losses	$	11,158,496		$	9,533,254
Total deferred tax asset		11,158,496			9,533,254
Deferred tax liabilities:
Canadian real estate		(3,039,417	)		(2,822,096	)
Total deferred tax liabilities		(3,039,417	)		(2,822,096	)
Valuation allowance		(8,119,079	)		(6,711,158	)
Net deferred tax liabilities	$	—		$	—

Schedule of Securities Excluded from Computation of Diluted Earnings Per Share

The following table presents the unconverted Series B Convertible Preferred Stock and unvested restricted stock awards, that were excluded from the computation of diluted earnings per share above as their effect would have been antidilutive for the respective periods, and was calculated using the treasury stock or if-converted method, as applicable:

	For the three months ended March 31,
	2025		2024
	Equivalent Shares (if converted)		Equivalent Shares (if converted)
Series B Convertible Preferred Stock		13,636,364		13,636,364
Unvested restricted stock awards		11,250		9,375
		13,647,614		13,645,739